期刊文献+

药物筛选新技术及其应用进展 被引量:12

Drug Screening New Technologies and Their Applications
下载PDF
导出
摘要 药物筛选是应用适当的筛选方法和筛选技术从海量化合物中筛选出具有药理活性的化合物的方法,是提高研发效率、缩短周期、减少成本、降低风险、使新药研发能够持续进行的关键。药物筛选新技术的开发已成为医药科学研究的重要内容。该文就近年来发展的药物筛选新技术及其应用进行了简要综述。 Drug screening is to apply the appropriate screening methods and screening technologies to extract the pharmacological active compounds from vast amounts of compounds. Drug screening is the key to improve the drug research efficiency,accelerate research cycle,cut down research cost and reduce investment risk,which makes the new drug research and development can be sustained. Drug screening new technologies have also become the important content of pharmaceutical research. More and more drug screening technologies have been developed,such as high throughput screening technology,high content screening technology,surface plasmon resonance technology and microfluidic chip technology,etc. These new drug screening technologies and their application are reviewed in this article.
出处 《分析测试学报》 CAS CSCD 北大核心 2015年第11期1324-1330,共7页 Journal of Instrumental Analysis
基金 国家自然科学基金项目(21375152)
关键词 药物筛选 高通量筛选 高内涵筛选 表面等离子体共振技术 微流控芯片 drug screening high throughput screening high content screening surface plasmon resonance(SPR) microfluidic chip
  • 相关文献

参考文献67

  • 1Balakin K V, Ivanenkov Y A, Savchuk N P. Methods Mol. Biol. , 2009, 575 : 21 -46.
  • 2Breinbauer R, Manger M, Scheck M, Waldmann H. Curr, Med. Chem.,2002, 9(23): 2129 -2145.
  • 3Suggitt M, Bibby M C. Clin. Cancer Res. , 2005, 11(3) : 971 -981.
  • 4杜冠华,胡娟娟,夏丽娟,黄家学,张均田.药物筛选的发展与现状[J].药学学报,1998,33(11):876-879. 被引量:32
  • 5杜冠华.药物筛选新技术与中药现代化研究[J].世界科学技术-中药现代化,2000,2(4):47-52. 被引量:26
  • 6Guido R V, Oliva G, Andricopulo A D. Comb. Chem. High Throughput Screen, 2011,14(10): 830 -839.
  • 7Silverman L, Campbell R, Broach J R. Curr. Opin. Chem. Biol.,1998,2(3) : 397 -403.
  • 8Mayr L M, Bojanic D. Curr. Opin. Pharmacol.,2009 , 9(5) : 580 -588.
  • 9Wunder F, Kalthof B, Miiller T, Htiser J. Comb. Chem. High Throughput Screen, 2008, 11(7): 495 -504.
  • 10Becker S, Schmoldt H U,Adams T M, Wilhelm S, Kolmar H. Curr. Opin, Biotechnol.,2004, 15(4) : 323 -329.

二级参考文献224

  • 1李洪林,沈建华,罗小民,沈旭,朱维良,王希诚,陈凯先,蒋华良.虚拟筛选与新药发现[J].生命科学,2005,17(2):125-131. 被引量:42
  • 2邹文进,刘祖国,蒋爱华,李朝阳.多西环素诱导单核细胞系THP-1凋亡的实验研究[J].中国病理生理杂志,2007,23(6):1195-1198. 被引量:6
  • 3嵇汝运,庆祝中国药学会成立九十周年暨第二十次全国会员代表大会论文集,1997年,39页
  • 4Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity : a leading role for STAT3. Nature Reviews [ J ] . Cancer, 2009, 9 ( 11): 798-809.
  • 5Zhang X, Yue P, Page BD, et al. Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts [ J ] . Proceedings of the National Academy of Sciences, 2012, 109 ( 24 ) : 9623-9628.
  • 6Spaccarotella E, Pellegrino E, Ferracin M, et al. STAT3-mediated activation of microRNA cluster 17-92 promotes proliferation and survival of ALK positive anaplastic large cell lymphoma [J]. Haematologica, 2014, 99 ( 1 ) : 116-124.
  • 7Grivennikov S, Karin E, Terzic J, et al. IL-6 and Stat3 are required for survival of intestinal epithelial ceils and development of colitis- associated cancer [ J ] . Cancer Cell, 2009, 15 ( 2 ) : 103-113.
  • 8Iwamaru A, Szymanski S, Iwado E, et al. A novel inhibitor of theSTAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo [ J ] . Oncogene, 2006, 26 ( 17 ) : 2435-2444.
  • 9Frank DA. STAT3 as a central mediator of neoplastic cellular transformation[J]. Cancer Letters, 2007, 251 ( 2 ) : 199-210.
  • 10Selvaraj BT, Frank N, Bender FL, et al. Local axonal function of ST- AT3 rescues axon degeneration in the pmn model of motoneuron dis- ease [ J ] . The Journal of Cell Biology, 2012, 199 ( 3 ) : 437-451.

共引文献66

同被引文献142

引证文献12

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部